volume 2, issue 6, P481-488 2013
DOI: 10.2217/bmt.13.51
View full text
|
|
Share

Abstract: SUMMARY The Notch signaling pathway has been shown to play a pivotal role in the etiology of breast cancer, as it is aberrantly activated in many forms of the disease, and sustained signaling through the pathway is required to maintain the transformed phenotype. These discoveries have resulted in significant interest in targeting the pathway in breast cancer treatment. Over the past decade, several Notch pathway inhibitors have entered the initial stages of clinical trials as monotherapies. However, recent da…

Expand abstract